Form D · Pharmaceuticals
PALATIN TECHNOLOGIES INC
Cranbury, NJ · CIK 0000911216
Offering snapshot reported Jul 13, 2012 · SEC filing
- Reported sold
- $35M Offering amount: $35M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 2, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2012 | Initial | $35,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-181225
Source: Form D, filed Jul 13, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert K. De Veer | Director |
| Alan W. Dunton | Director |
| Zola P. Horovitz | Director |
| Joseph Stanley Hull | Director |
| Perry B. Molinoff | Director |
| John K. A. Prendergast | Director |
| Carl Spana | Director, Executive |
| Robert I. Taber | Director |
| Stephen T. Wills | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4 B Cedar Brook Drive
Cranbury, NJ, 08512
Cranbury, NJ, 08512